🇺🇸
United States · US · US:0480-8725_8f65417f-488f-4e4a-894c-56f99ed57d25
Levothyroxine sodium
In shortageOrange BookUNIISPLATC H03AA01
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerTeva Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeH03AA01
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 2
- ndc1104808725101000 TABLET in 1 BOTTLE (0480-8725-10)
- ndc11048087259890 TABLET in 1 BOTTLE (0480-8725-98)
Annotations
UNII (FDA Substance ID)
9J765S329G
LEVOTHYROXINE SODIUM
RxCUI 40144
Orange Book
A207588
AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4AB1,AB2,AB3,AB4
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Levothyroxine Sodium Tablet
Raw payload (JSON)
{
"unii": {
"unii": "9J765S329G",
"rxcui": "40144",
"inchikey": "JMHCCAYJTTWMCX-QWPJCUCISA-M",
"display_name": "LEVOTHYROXINE SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"5852d874-1ebc-49ff-b6c2-1dd513fca784": {
"match": "brand_token",
"title": "LEVOTHYROXINE SODIUM TABLET [BRYANT RANCH PREPACK]",
"spl_version": "102",
"published_date": "2026-05-28"
}
},
"productid": "0480-8725_8f65417f-488f-4e4a-894c-56f99ed57d25",
"productndc": "0480-8725",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "207588",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "001",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "002",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "003",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "004",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "005",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "006",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "007",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "008",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "009",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "010",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "011",
"approval_date": "May 10, 2022"
},
{
"rs": false,
"rld": false,
"te_code": "AB1,AB2,AB3,AB4",
"strength": "0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium",
"product_no": "012",
"approval_date": "May 10, 2022"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "LEVOTHYROXINE SODIUM",
"shortage_reason": "Levothyroxine Sodium Tablet",
"shortage_status": "current",
"proprietary_name": "Levothyroxine sodium",
"active_ingred_unit": "ug/1",
"application_number": "ANDA207588",
"marketing_category": "ANDA",
"nonproprietary_name": "Levothyroxine sodium",
"start_marketing_date": "20220921",
"active_numerator_strength": "300"
}Related drugs
Other records sharing ATC code H03AA01.
Access this data programmatically
Query Levothyroxine sodium and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.